Furthermore, promoter regions of IGF1 were concomitantly demethylated upon treatment of 5-AzaC (Supplementary Fig. 18), supporting promoter hypomethylation as one of the mechanisms for activation of the IGF1/IGF1R pathway in gastric cancer. This evidence concerns the gene IGF1 and gastric cancer.